A case of malignant pericardial effusion secondary to gastric adenocarcinoma

    Authors

    Keywords

    cardiac tamponade, gastric cancer, malignant pericardial effusion, pericardiocentesis

    DOI

    https://doi.org/10.15836/ccar2024.561

    Full Text

    **Introduction:** Malignant pericardial effusion is a critical and often life-threatening condition that can lead to development of cardiac tamponade, hemodynamic instability, and if untreated, death (1). **Case report:** We report the case of a 32-year-old female who presented to the Emergency Department with a two-week history of dry cough, dyspnea on exertion, loss of appetite, and food aversion. Physical examination revealed multiple palpable lymph nodes and absent breath sounds over the lower half of the left lung. Laboratory tests showed mild microcytic anemia. The patient was hospitalized in the Department of Pulmonology, where tumor markers, including CA 19-9, CA 72-4, PIVKA-II, and CA 125, were positive. An axillary lymph node excision was performed, and CT of the thorax, abdomen, and pelvis revealed bilateral pleural effusions, pericardial effusion, and free abdominal fluid. Echocardiography confirmed minimal pericardial effusion. The patient underwent multiple left-sided thoracocenteses, both during hospitalization and outpatient follow-up. Pathohistology of the excised lymph node revealed signet ring cells, leading to an esophagogastroduodenoscopy, which confirmed gastric adenocarcinoma through a gastric ulcer biopsy. She was later hospitalized in the Department of Oncology, where staging confirmed disseminated disease, and she began chemotherapy and radiotherapy. After initial relief, the patient was readmitted two days post-discharge with dyspnea. A thoracic CT showed extensive pericardial effusion (**Figure 1**), and echocardiography revealed signs of impending cardiac tamponade. Emergent pericardiocentesis removed 900 ml of hemorrhagic fluid. Chemotherapy and supportive measures were continued, but within a month, another pericardiocentesis removed 700 ml of fluid. Despite interventions, the patient died months later due to disease progression. FIGURE 1. Thoracic CT showing extensive pericardial effusion. **Conclusion:** Any cancer can metastasize to the pericardium, causing effusion through increased vascular permeability or lymphatic obstruction, with breast, lung, and Hodgkin lymphoma being the most common culprits (2). Malignant pericardial effusion in advanced gastric adenocarcinoma has a poor prognosis despite timely interventions, with survival remaining limited in widespread disease.

    Literature

    1. Mudra SE, Rayes D, Kumar AK, Li JZ, Njus M, McGowan K, et al. Malignant Pericardial Effusion: A Systematic Review. CJC Open. 2024 May 15;6(8):967–72. https://doi.org/10.1016/j.cjco.2024.05.003
    2. Ghosh AK, Crake T, Manisty C, Westwood M. Pericardial Disease in Cancer Patients. Curr Treat Options Cardiovasc Med. 2018 June 23;20(7):60. https://doi.org/10.1007/s11936-018-0654-7
    Cardiologia Croatica
    Back to search

    A case of malignant pericardial effusion secondary to gastric adenocarcinoma

    Extended Abstract
    Issue11-12
    Published
    Pages561
    PDF via DOIhttps://doi.org/10.15836/ccar2024.561
    cardiac tamponade
    gastric cancer
    malignant pericardial effusion
    pericardiocentesis

    Authors

    Matea Mamić*ORCIDUniversity of Rijeka, Rijeka, Croatia
    Ivana PeršićORCIDUniversity of Rijeka, Rijeka, Croatia
    Fabio KadumORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Kristina UglešićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Teodora Zaninović JurjevićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia

    *Correspondence email: matea.mamic4@gmail.com

    Full Text

    Introduction: Malignant pericardial effusion is a critical and often life-threatening condition that can lead to development of cardiac tamponade, hemodynamic instability, and if untreated, death (1).

    Case report: We report the case of a 32-year-old female who presented to the Emergency Department with a two-week history of dry cough, dyspnea on exertion, loss of appetite, and food aversion. Physical examination revealed multiple palpable lymph nodes and absent breath sounds over the lower half of the left lung. Laboratory tests showed mild microcytic anemia. The patient was hospitalized in the Department of Pulmonology, where tumor markers, including CA 19-9, CA 72-4, PIVKA-II, and CA 125, were positive. An axillary lymph node excision was performed, and CT of the thorax, abdomen, and pelvis revealed bilateral pleural effusions, pericardial effusion, and free abdominal fluid. Echocardiography confirmed minimal pericardial effusion. The patient underwent multiple left-sided thoracocenteses, both during hospitalization and outpatient follow-up. Pathohistology of the excised lymph node revealed signet ring cells, leading to an esophagogastroduodenoscopy, which confirmed gastric adenocarcinoma through a gastric ulcer biopsy. She was later hospitalized in the Department of Oncology, where staging confirmed disseminated disease, and she began chemotherapy and radiotherapy. After initial relief, the patient was readmitted two days post-discharge with dyspnea. A thoracic CT showed extensive pericardial effusion (Figure 1), and echocardiography revealed signs of impending cardiac tamponade. Emergent pericardiocentesis removed 900 ml of hemorrhagic fluid. Chemotherapy and supportive measures were continued, but within a month, another pericardiocentesis removed 700 ml of fluid. Despite interventions, the patient died months later due to disease progression.

    FIGURE 1. Thoracic CT showing extensive pericardial effusion.

    Conclusion: Any cancer can metastasize to the pericardium, causing effusion through increased vascular permeability or lymphatic obstruction, with breast, lung, and Hodgkin lymphoma being the most common culprits (2). Malignant pericardial effusion in advanced gastric adenocarcinoma has a poor prognosis despite timely interventions, with survival remaining limited in widespread disease.

    Literature

    1. 1.
      Mudra SE, Rayes D, Kumar AK, Li JZ, Njus M, McGowan K, et al. Malignant Pericardial Effusion: A Systematic Review. CJC Open. 2024 May 15;6(8):967–72.DOI
    2. 2.
      Ghosh AK, Crake T, Manisty C, Westwood M. Pericardial Disease in Cancer Patients. Curr Treat Options Cardiovasc Med. 2018 June 23;20(7):60.DOI